Parkside Financial Bank & Trust’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $152K | Sell |
270
-3
| -1% | -$1.92K | 0.01% | 534 |
|
|
2025
Q4 | $185K | Buy |
273
+15
| +6% | +$10.2K | 0.01% | 477 |
|
|
2025
Q3 | $165K | Buy |
258
+3
| +1% | +$1.82K | 0.01% | 497 |
|
|
2025
Q2 | $137K | Buy |
255
+10
| +4% | +$4.78K | 0.01% | 539 |
|
|
2025
Q1 | $103K | Buy |
245
+8
| +3% | +$3.47K | 0.01% | 573 |
|
|
2024
Q4 | $98K | Sell |
237
-10
| -4% | -$4.39K | 0.01% | 581 |
|
|
2024
Q3 | $125K | Sell |
247
-4
| -2% | -$1.94K | 0.02% | 483 |
|
|
2024
Q2 | $122K | Buy |
251
+9
| +4% | +$4.52K | 0.02% | 463 |
|
|
2024
Q1 | $131K | Sell |
242
-19
| -7% | -$10.4K | 0.02% | 449 |
|
|
2023
Q4 | $145K | Buy |
261
+8
| +3% | +$3.76K | 0.03% | 379 |
|
|
2023
Q3 | $111K | Buy |
253
+45
| +22% | +$22.4K | 0.03% | 388 |
|
|
2023
Q2 | $104K | Buy |
208
+2
| +1% | +$958 | 0.02% | 399 |
|
|
2023
Q1 | $103K | Sell |
206
-3
| -1% | -$1.44K | 0.03% | 382 |
|
|
2022
Q4 | $85.3K | Sell |
209
-345
| -62% | -$134K | 0.02% | 425 |
|
|
2022
Q3 | $181K | Buy |
554
+4
| +0.7% | +$1.47K | 0.06% | 229 |
|
|
2022
Q2 | $193K | Buy |
550
+80
| +17% | +$32.6K | 0.06% | 227 |
|
|
2022
Q1 | $257K | Sell |
470
-402
| -46% | -$211K | 0.07% | 200 |
|
|
2021
Q4 | $574K | Buy |
872
+741
| +566% | +$465K | 0.14% | 117 |
|
|
2021
Q3 | $81K | Buy |
131
+21
| +19% | +$14.1K | 0.02% | 368 |
|
|
2021
Q2 | $69K | Buy |
110
+6
| +6% | +$3.31K | 0.02% | 409 |
|
|
2021
Q1 | $51K | Buy |
104
+46
| +79% | +$23K | 0.02% | 476 |
|
|
2020
Q4 | $29K | Buy |
58
+8
| +16% | +$3.58K | 0.01% | 611 |
|
|
2020
Q3 | $20K | Sell |
50
-1
| -2% | -$370 | 0.01% | 644 |
|
|
2020
Q2 | $17K | Buy |
51
+8
| +19% | +$2.32K | 0.01% | 683 |
|
|
2020
Q1 | $10K | Sell |
43
-1
| -2% | -$261 | ﹤0.01% | 721 |
|
|
2019
Q4 | $11K | Buy |
44
+6
| +16% | +$1.58K | ﹤0.01% | 781 |
|
|
2019
Q3 | $10K | Hold |
38
| – | – | ﹤0.01% | 778 |
|
|
2019
Q2 | $10K | Buy |
38
+9
| +31% | +$2.22K | ﹤0.01% | 803 |
|
|
2019
Q1 | $6K | Sell |
29
-43
| -60% | -$8.88K | ﹤0.01% | 892 |
|
|
2018
Q4 | $13K | Sell |
72
-26
| -27% | -$5.33K | ﹤0.01% | 684 |
|
|
2018
Q3 | $25K | Sell |
98
-15
| -13% | -$3.64K | 0.01% | 539 |
|
|
2018
Q2 | $25K | Buy |
113
+1
| +0.9% | +$206 | 0.01% | 528 |
|
|
2018
Q1 | $22K | Hold |
112
| – | – | 0.01% | 546 |
|
|
2017
Q4 | $17K | Sell |
112
-42
| -27% | -$6.61K | 0.01% | 614 |
|
|
2017
Q3 | $24K | Sell |
154
-12
| -7% | -$1.9K | 0.01% | 490 |
|
|
2017
Q2 | $27K | Buy |
166
+11
| +7% | +$1.79K | 0.01% | 462 |
|
|
2017
Q1 | $24K | Sell |
155
-38
| -20% | -$5.24K | 0.01% | 482 |
|
|
2016
Q4 | $23K | Sell |
193
-32
| -14% | -$3.65K | 0.01% | 505 |
|
|
2016
Q3 | $25K | Sell |
225
-21
| -9% | -$2.21K | 0.01% | 517 |
|
|
2016
Q2 | $23K | Hold |
246
| – | – | 0.01% | 517 |
|
|
2016
Q1 | $19K | Buy |
246
+28
| +13% | +$2.02K | 0.01% | 527 |
|
|
2015
Q4 | $16K | Buy |
218
+26
| +14% | +$1.85K | 0.01% | 559 |
|
|
2015
Q3 | $14K | Buy |
+192
| New | +$13.8K | 0.01% | 562 |
|
Other funds holding IDXX
VCM
VPM
Parkside Financial Bank & Trust's IDXX Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Idexx Laboratories (IDXX) stake by 1.1% in Q1 2026, selling an estimated $1.92K and leaving 270 shares worth $152K. The position accounts for 0.01% of the portfolio, ranked #534.
Parkside Financial Bank & Trust first reported a position in IDXX in Q3 2015 and has held it in 43 quarters since. The position peaked at $574K in Q4 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Parkside Financial Bank & Trust held 270 shares of Idexx Laboratories worth $152K as of Q1 2026.
- Parkside Financial Bank & Trust sold 3 Idexx Laboratories shares in Q1 2026, an estimated $1.92K.
- Idexx Laboratories made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #534 holding.
- Parkside Financial Bank & Trust first reported a position in Idexx Laboratories in Q3 2015 and has held it in 43 quarters since.
- Parkside Financial Bank & Trust's Idexx Laboratories position peaked at $574K in Q4 2021.
- 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.